Johnson & Johnson (JNJ) tops revenue estimates, reiterates forecast

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. INTC
2. SPCX
3. DSX
4. GNK
5. AWK
6. MDA
7. ACN
8. NTMFF
9. III
10. SAN

Go back to Johnson & Johnson (JNJ) tops revenue estimates, reiterates forecast

Johnson & Johnson Reports Q4 and Full-Year 2023 Results

January 23, 2024 6:20 AM EST

2023 Fourth-Quarter reported sales growth of 7.3% to $21.4 Billion with operational growth of 7.2%* and adjusted operational growth of 5.7%*. Operational growth excluding COVID-19 Vaccine of 10.9%* 2023 Fourth-Quarter Earnings per share (EPS) of $1.70 increasing 39.3% and adjusted EPS of $2.29 increasing by 11.7%*  2023 Full-Year reported sales growth of 6.5% to $85.2 Billion with operational growth of 7.4%* and adjusted operational growth of 5.9%*. Operational growth excluding COVID-19 Vaccine of 9.0%* 2023 Full-Year EPS of $5.20 decreasing 15.3% due to a special one-time charge in the First-Quarter, and adjusted EPS of $9.92 increasing by 11.1%*  Company re-confirms guidance for 2024 with operational sales5 growth of 5.0% - 6.0%* and adjusted... More